VHL and nonpapillary renal cell carcinoma: Rare mutations in several genes confer high penetrance susceptibility to ccRCC (including VHL, BAP1, FLCN, PTEN, MET, SDHD, ELOC, TSC1)4–6, however these account for <5% of cases and little of the two-fold familial risk.